| Fund | Type | Gross assets | Min. |
|---|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | Venture Capital | $661.6M | $5M |
| Decheng Capital China Life Sciences Usd Fund III, L.P. | Venture Capital | $503.7M | $5M |
| Decheng Capital Global Life Sciences Fund V, L.P. | Venture Capital | $317M | $5M |
| Name | Title | Ownership | Since |
|---|---|---|---|
| Hongbo Nmn Bao | Chief Compliance Officer | Under 5% | 2024 |
| Xiangmin Nmn Cui Control | Managing Director | Over 75% | 2011 |
| Yuheng Nmn Qiu | Chief Financial Officer | Under 5% | 2024 |
Decheng Capital LLC reports $2.1 billion in regulatory assets under management on its Form ADV.
Decheng Capital LLC manages 8 private funds with combined gross assets of $2.1 billion.
Decheng Capital LLC reports 24 employees.
Decheng Capital LLC is based in Menlo Park, CA and has been SEC-registered since 2020.
Decheng Capital LLC is not required to publicly disclose fund returns. Form ADV filings include assets, ownership, and service providers, shown above.
| Address | 3000 Sand Hill Road, Building 2, Suite 110, Menlo Park, CA 94025 |
| Phone | 650-382-5514 |
| Office hours | 9a.m. - 5p.m. |
| SEC region | San Francisco Regional Office (SFRO) |
| Umbrella registration | Yes |
| Discloses disciplinary history | No |
| Discretionary | $2.15B |
| Non-discretionary | $0 |
| Total (RAUM) | $2.15B |